Vitreoretinal Division, King Khaled Eye Specialist Hospital, Riyadh, Saudi Arabia.
King Faisal University, Al-Ahsa, Saudi Arabia.
Middle East Afr J Ophthalmol. 2021 Apr 30;28(1):57-59. doi: 10.4103/meajo.MEAJO_139_20. eCollection 2021 Jan-Mar.
The purpose of the study is to report a case of peripheral exudative hemorrhagic chorioretinopathy (PEHCR), managed surgically with favorable visual outcome. A 66-year-old female presented with painless visual loss due to dense vitreous and subretinal hemorrhage extending from the far periphery to the macula. Pars plana vitrectomy (PPV) with subretinal tissue plasminogen activator (TPA) injection was performed resulting in good anatomical and visual outcome. PEHCR can present with severe visual loss. Surgical management with PPV and subretinal TPA injection might result in favorable anatomical and visual outcome.
本研究旨在报告一例外周渗出性出血性脉络膜视网膜病变(PEHCR),经手术治疗后视力预后良好。一名 66 岁女性因远周边至黄斑的弥漫性玻璃体积血和视网膜下出血导致无痛性视力丧失就诊。行玻璃体切除术(PPV)联合视网膜下组织型纤溶酶原激活剂(t-PA)注射,术后解剖和视力均取得良好结果。PEHCR 可导致严重视力丧失。PPV 联合视网膜下 t-PA 注射的手术治疗可能会获得良好的解剖和视力预后。